Topic

Illinois

A collection of 499 issues

How to Get Increlex (Mecasermin) Covered by Humana in Illinois: Decision Tree & Appeal Guide

Quick Answer: Increlex (mecasermin) coverage by Humana requires severe primary IGF-1 deficiency diagnosis with height SDS ≤ -3.0, IGF-1 SDS ≤ -3.0, and normal/elevated growth hormone levels. Contact Humana Clinical Pharmacy Review at 800-555-2546 for prior authorization. If denied, Illinois residents have strong appeal rights including automatic external review.

Myths vs. Facts: Getting Humira (adalimumab) Covered by Blue Cross Blue Shield in Illinois

Answer Box: Getting Humira Covered by BCBS Illinois The Reality: Blue Cross Blue Shield of Illinois requires prior authorization for Humira and strongly prefers biosimilars in 2025. Success depends on documenting biosimilar failure/intolerance and meeting specific clinical criteria. Fastest Path: 1) Check your plan's current formulary status,

UnitedHealthcare's Coverage Criteria for Mycapssa (Octreotide, Oral) in Illinois: What Counts as "Medically Necessary"?

Answer Box: Getting Mycapssa Covered by UnitedHealthcare in Illinois To get Mycapssa (oral octreotide) approved by UnitedHealthcare in Illinois, you must meet all of these criteria: confirmed acromegaly diagnosis with elevated IGF-1 or GH levels, documented prior response to injectable octreotide or lanreotide, clinical justification for switching to oral therapy,

Do You Qualify for Turalio (Pexidartinib) Coverage by Aetna (CVS Health) in Illinois? Decision Tree & Next Steps

Quick Answer: Your Path to Turalio Approval Yes, Aetna (CVS Health) covers Turalio (pexidartinib) in Illinois with prior authorization. You'll likely qualify if you have symptomatic TGCT not suitable for surgery, meet REMS program requirements, and provide complete documentation. First step today: Call CVS Specialty at 1-800-237-2767 to

How to Get Mavenclad (Cladribine Tablets) Covered by Blue Cross Blue Shield of Illinois: Requirements, Forms & Appeal Process

Answer Box: Getting Mavenclad Covered by BCBS Illinois Yes, Blue Cross Blue Shield of Illinois covers Mavenclad (cladribine tablets) with prior authorization. The fastest path: (1) Verify your plan requires PA through Availity Essentials, (2) Submit complete clinical documentation showing relapsing MS diagnosis (ICD-10: G35.A or G35.C1) and

How to Get Symdeko/Symkevi Covered by Cigna in Illinois: Prior Authorization Forms, Appeals Timeline & Documentation Guide

Quick Answer: Getting Symdeko/Symkevi Approved by Cigna in Illinois Eligibility: Cigna covers Symdeko (tezacaftor/ivacaftor) for cystic fibrosis patients age 6+ with specific CFTR mutations, prescribed by a pulmonologist or CF specialist. Fastest path: Have your CF specialist submit prior authorization with genetic testing results, clinical notes, and medical

Work With Your Doctor to Get Helixate (Antihemophilic Factor, rFVIII) Covered by Humana in Illinois: Provider Partnership Guide

Quick Answer: Getting Helixate Covered by Humana in Illinois Yes, Humana Medicare Advantage requires prior authorization for Helixate (recombinant Factor VIII) in Illinois. The fastest path to approval is working closely with your hematologist to submit comprehensive documentation through Humana's online portal or by calling 800-523-0023. Your first

How to Get Rylaze Covered by Aetna CVS Health in Illinois: Complete PA Guide & Appeal Process

Answer Box: Getting Rylaze Covered by Aetna CVS Health in Illinois Rylaze requires prior authorization from Aetna CVS Health for ALL/LBL patients with documented E. coli asparaginase hypersensitivity. Submit Aetna's specialty drug PA form with clinical notes proving hypersensitivity reaction, ALL/LBL diagnosis, and treatment plan. Use

How to Get Vanflyta (quizartinib) Covered by Blue Cross Blue Shield of Illinois: Complete PA Guide and Appeal Process

Answer Box: Getting Vanflyta Covered in Illinois Vanflyta (quizartinib) requires prior authorization from Blue Cross Blue Shield of Illinois for FLT3-ITD positive AML. Submit the Illinois Uniform Prior Authorization Form with FLT3-ITD mutation testing, cardiac monitoring plan, and REMS enrollment documentation. If denied, you have 180 days for internal appeal

How to Get Jaypirca (Pirtobrutinib) Covered by UnitedHealthcare in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Jaypirca Covered by UnitedHealthcare in Illinois UnitedHealthcare requires prior authorization for Jaypirca (pirtobrutinib) with mandatory step therapy—you must document failure or intolerance to at least one other BTK inhibitor (ibrutinib, acalabrutinib, or zanubrutinib) before approval. For CLL/SLL patients, prior BCL-2 inhibitor failure is also required.